Drug maker loses battle over Canada's right to impose a price cap - STAT
Alexion Pharmaceuticals, The European Awards in Medicine 2019, Biopharmacology | El Suplemento
AstraZeneca concludes Alexion acquisition for $39bn
ALEXION PHARMACEUTICALS, INC. - ALEXION'S NEXT CHAPTER Our Next Chapter & Advances shared mission of following the science and using innovative approaches to develop life-changing medicines for patientsStrengthens AstraZeneca's presence in immunology
Alexion Pharmaceuticals, Inc. | LinkedIn
Alexion Pharmaceuticals – The New Economy
ALEXION PHARMA FRANCE Overview | SignalHire Company Profile
AstraZeneca to Acquire Alexion for $39B, Adding Rare Disease, Immunology Assets